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Abstract 
 
Background and purpose: Migraine with aura (MA) is considered as a risk factor for 
ischaemic stroke. The present obser vational retrospective study compares migraine 
patients admitted for a documented stroke with those presenting focal neurological 
symptoms and headache without a demonstrable lesion and in which the final diagnosis was a 
migraine attack with aura. 
Material and methods: The study included 14 migraine patients with a stroke and 37 without 
a stroke. The clinical characteristics, the vascular risk factors and the results of the 
technical examinations were compared. 
Results: Stroke occurred in migraine patients with aura as well as without aura. Classical 
vascular risk factors were rather rare. Patent foramen ovale (PFO) with or without atrial 
septum aneurysm appeared to be the main risk factor for stroke in patients with a history 
of migraine. Infarcts were mainly located in the supratentorial territory of the posterior 
cerebral circulation. Also some lobar haematomas were observed, but their aetiology 
remained uncertain. The strokes were generally mildly severe with good outcome. 
Hyperintense signals in the cerebral white matter and cerebellum, on T2-weighted magnetic 
resonance imaging, were more frequent in the migraine patients with stroke. 
Conclusions: The presence of PFO, rather than of MA, appeared to be the main risk factor 
for stroke patients with migraine. No direct relation between migraine and stroke could be 
demonstrated. 
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Introduction 
 
Migraine with aura (MA) is an established risk factor 
for ischaemic lesions of the brain, especially in 
women of childbearing age using contraceptives containing 
oestrogen [1]. There is also evidence that MA 
is linked to a broader range of ischaemic vascular disorders 
such as coronary and peripheral artery diseases 
[2]. In addition, individuals with migraine have a higher 
incidence of vascular risk factors, including arterial 
hypertension, diabetes and hyperlipidaemia [3]. However, 
migraine does not appear to predispose to atherosclerosis 
but is associated with a higher risk of venous 
thromboembolism [4]. Patent foramen ovale (PFO) 
appears to occur more frequently in patients with MA 
than in the general population and in migraine patients 
without aura (MO) [5]. 
Several hereditary conditions, such as cerebral autosomal 
dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL), mitochondrial 
myopathy, encephalopathy, lactic acidosis and strokelike 
episodes (MELAS), and hereditary haemorrha gic 
telangiectasia appear to predispose to both migraine and 
stroke [6]. 
Clinical infarcts in patients with migraine are suggested 
to occur mainly in the posterior cerebral circulation, 
notably in the occipital lobes [7-13], although 
more recent studies stress a preferential location in the 
brainstem [14] and in the cerebellum [15]. 
However, both migraine and stroke are common and 
co-morbidity may, in some cases, be coincidental [16]. 
The present pilot study compares patients with 
a prior history of migraine with or without aura, who 
were admitted for an acute stroke or an episode of severe 
headache, accompanied by temporary focal neurological 
symptoms, in whom no cerebrovascular lesion was 
detected and in whom the final diagnosis was a migraine 
attack with aura. 
 
Material and methods 
 
This open observational retrospective study concerns 
51 patients, out of a series of 1617 consecutively admitted 
to the Stroke Unit of the Ghent University Hospital 
between 2001 and 2007, who had a prior history of 
migraine and an episode of focal neurological deficit with 
or without severe headache. The patients were subdivided 
into 14 subjects with a documented stroke and 37 subjects 
in whom no cerebrovascular lesion was detected. 
The migraine patients were classified into those with 
a prior history of MA and those with MO, according 
to the “International Headache Classification” [17], 
apart from the episode leading to the final admission. 
The demographic features, including the vascular 
risk factors, were available in all patients. A family history 
investigation concerning migraine and stroke was 
only available in 51% of all patients. The degree of neurological 
impairment on admission, assessed with the 
National Institutes of Health Stroke Scale (NIHSS) 
[18], and the degree of disability on the modified 
Rankin scale (mRS) [19] at discharge, were compared 
between the two groups. All patients underwent neuroimaging 
of the brain: 69% of the patients had computed 
tomography (CT) and 88% had magnetic resonance 
imaging (MRI) of the brain during admission, 
including T2- and diffusion-weighted imaging. 
All patients had an extensive blood analysis, including 
rare blood clotting disorders. Mutations in the 
NOTCH3 gene were only investigated in 3 patients with 
a history of migraine, stroke, severe white matter 
changes in the cerebral hemispheres on MRI and 
a fami ly history of migraine, stroke and dementia. 
A transoesophageal Doppler examination of the 
heart was performed in 71% of all patients, but in all of 
those who had a stroke. No transthoracic echography 
was done, as it is not sensitive enough to detect PFO. 
No search for peripheral venous thrombosis was performed 
in the patients with PFO. Conventional or MR angiography of the extra- and 
intracranial vessels was done in 96% of the total study 
population and in all stroke patients. 
Statistical analysis was performed with R (a language 
and environment for statistical computing) [20]. Univariate 
comparison of unpaired groups was done with 
Fisher’s exact test for categorical data. The non-parametric 
Mann-Whitney U-test was used to compare 
unpaired continuous variables. The significance level 
was set at α = 0.05, two-tailed. 
 
Results 
 
No statistical differences were observed between the 
stroke and the non-stroke patients concerning age 
(p = 0.45) and gender distribution (p = 0.20) (78.6% 
and 56.8% were women, respectively). A history of MA 
was present in 42.9% of the stroke patients and in 51.4% 
of the non-stroke patients (p = 0.76). Headache accompanied 
stroke onset in 78.6% of patients. 
A family history of migraine was present in 77.8% of 
the stroke group and in 50.0% of the non-stroke patients 
(p = 0.23). A family history of stroke was obtained in 
22.2% and in 16.7%, respectively (p = 1.00). 
The incidence of classical age-related vascular risk 
factors was low in both groups and was not significantly 
different between them. 
Transoesophageal Doppler examination showed 
presence of PFO in 64.3% (35.7% with an atrial septum 
aneurysm) of the stroke group while it was absent 
in the non-stroke patients (p < 0.001). 
The median NIHSS score was also low in both 
groups but was statistically different between groups 
(p < 0.001). The median mRS scores were also low and 
also significantly different between groups (p < 0.001) 
(Table 1). 
Protein C deficiency was observed in 14.3% of the 
stroke patients, but was absent in the non-stroke group 
(p = 0.071). One stroke patient had significantly 
increased homocysteine plasma level of 37.2 μmol/l. 
Mutations in the NOTCH3 gene were not observed in 
the 3 examined patients. 
Conventional or MR angiography showed only 
abnormalities in the former group (p = 0.020), con- 
sisting of carotid dissection in 1 patient, moderate 
atherosclerosis of the internal carotid artery in 1 patient 
and moderate atherosclerosis of a vertebral artery in 
another 1 patient. 
In the stroke group, a lobar haematoma was found 
in 14.3% and ischaemic lesions in 85.7%, of which 
58.3% were located in the posterior and 41.7% in the 
anterior circulation. 
A supratentorial infarct or haematoma was observed 
on CT and/or MRI in 13 out of the 14 stroke patients. 
In 1 patient a cerebellar infarct was observed. Additional 
small white matter T2 signals on MRI were seen in 
42.9% of the stroke group and in 12.1% of the nonstroke 
group (p = 0.046). In the former group, 33.3% 
of the signals were present in the cerebellum, while they 
were not observed in the latter group (p = 0.50). 
Combining migraine history, female gender, use of 
oestrogen and smoking was found not to be statistically 
different between the groups: 14.3% of the stroke 
patients and 5.4% of the non-stroke ones (p = 0.30). 
 
Discussion 
 
This retrospective observational study investigates 
the occurrence of stroke in migraine patients who developed 
an episode of focal neurological disturbances. Due 
to the small number of patients the results have to be 
interpreted with some circumspection. We cannot 
exclude that we have missed a migraine history in some 
patients admitted to our Stroke Unit, as the overall incidence 
was only 3.2%. As the one-year prevalence of 
migraine in the general population is estimated to be about 
6% in males and 15 to 18% in females [21], it is probable 
that some admitted patients forgot to mention prior 
migraine attacks, considered by them as not relevant. 
In the present study, a prior history of MA was not 
more frequent than of MO in the stroke patients, 
although this is considered as a significant risk factor 
[22,23]. We could also not demonstrate that young 
women with MA, using oestrogens and smoking, have 
an increased risk of stroke [24]. 
On the other hand, the predominance of infarcts in 
the supratentorial territory of the posterior circulation 
was confirmed [7-13,25]. The percentage incidence 
was 58.3%, which is much higher than the 12.5% 
observed in the overall stroke population admitted to 
the Stroke Unit of the Ghent University Hospital [26]. 
Also two cases of temporal lobar haematoma were 
found. Both young patients had only arterial hyperten- 
sion as a risk factor. No vascular malformation could be 
demonstrated on angiography. 
Although a high incidence of PFO in patients with 
MA has been demonstrated [27], their causal relation 
remains uncertain [28]. Factors that may contribute to 
stroke in migraine include changes during cortical 
spreading depression with hyper- or hypoperfusion of 
neural tissue, vasospasm and endothelial dysfunction. 
Co-morbidity with PFO can be a mechanism of both 
disorders via a presumed lack of filtration of microemboli 
or toxic substances [29]. 
In the present study, 74.3% of the stroke patients 
had a PFO (half of them with an atrial septum 
aneurysm), while in the non-stroke group no PFO was 
observed. Both groups consisted of young patients. 
Although the occurrence of PFO has been estimated to 
be between 20 and 25% in migraine patients without 
stroke [5], the difference with our stroke patients should 
still remain significant. The present study did not investigate 
the possibility of paradoxical emboli in the patients 
with stroke and PFO. 
PFO and stroke were equally observed in patients 
with MA as with MO. Previous studies have shown 
that patients with migraine and a cryptogenic stroke 
have significantly larger PFOs than migraine patients 
without stroke [30]. Also patients with PFO associated 
with an atrial septum aneurysm have an increased 
risk of cerebral ischaemic events [31]. 
So, in our small series of migraine patients PFO 
appears to be the major cause of cryptogenic ischaemic 
stroke. Carotid dissection has to be excluded as a rare 
cause. One older patient with an ischaemic stroke had 
hyperhomocysteinaemia as a possible vascular risk factor 
[32]. It remains uncertain what the cause of the lobar 
haematomas could be. The arterial hypertension of both 
young patients was well controlled and a cerebrovascular 
malformation could not be demonstrated on angiography. 
We could also show the presence of small T2-weighted 
hypersignals on MRI in the cerebral white matter 
and in the cerebellum, mainly in the migraine patients 
with a stroke [15,33]. Although the differences between 
the stroke and the non-stroke group were not statistically 
significant, T2-weighted hypersignals in the cerebellar 
white matter were only observed in the stroke 
patients with migraine, in addition to one patient with 
a documented cerebellar infarct. These white matter signals 
are not more frequent in migraine patients with 
PFO [34]. They are not associated with cognitive 
deficits in middle-aged subjects and their significance 
remains unclear [35]. 
 
Conclusion 
 
1. The present study demonstrates that PFO is the main 
risk factor for ischaemic stroke in migraine patients. 
2. We found no evidence that MA itself was the cause 
of the strokes. 
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Table 1: Comparison of demographic and clinical features, and vascular risk factors between migraine 
patients with and without stroke 
 
 
